Vivus ED drug will be bought in Europe, Australia, New Zealand with Menarini deal

Vivus ED drug will be sold in Europe, Australia, New Zealand with Menarini offer
(Reuters) – Vivus Inc, which is below extreme strain from its leading shareholder in excess of its marketing and advertising, explained it signed a deal worth up to 95 million euros ($ 121.47 million) with Italy's Menarini Group to introduce its erectile dysfunction drug in Europe …
Study much more on MedCity Information